nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP3A4—bone cancer	0.557	1	CbGaD
Benzphetamine—POR—Doxorubicin—bone cancer	0.318	0.737	CbGbCtD
Benzphetamine—CYP2B6—Cisplatin—bone cancer	0.0606	0.14	CbGbCtD
Benzphetamine—CYP2B6—Doxorubicin—bone cancer	0.0406	0.094	CbGbCtD
Benzphetamine—CYP3A4—Doxorubicin—bone cancer	0.0125	0.0289	CbGbCtD
Benzphetamine—POR—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00216	0.37	CbGpPWpGaD
Benzphetamine—POR—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000427	0.0732	CbGpPWpGaD
Benzphetamine—Oxaprozin—PTGS2—bone cancer	0.000415	0.0827	CrCbGaD
Benzphetamine—Toremifene—CYP3A4—bone cancer	0.000372	0.0741	CrCbGaD
Benzphetamine—Alimemazine—CYP3A4—bone cancer	0.000349	0.0695	CrCbGaD
Benzphetamine—Cyclobenzaprine—CYP3A4—bone cancer	0.000321	0.064	CrCbGaD
Benzphetamine—Phenprocoumon—CYP3A4—bone cancer	0.000302	0.0602	CrCbGaD
Benzphetamine—Phenylbutazone—CYP3A4—bone cancer	0.00028	0.0558	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS2—bone cancer	0.000274	0.0547	CrCbGaD
Benzphetamine—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000268	0.046	CbGpPWpGaD
Benzphetamine—Propafenone—CYP3A4—bone cancer	0.000262	0.0522	CrCbGaD
Benzphetamine—Levomethadyl Acetate—CYP3A4—bone cancer	0.000251	0.05	CrCbGaD
Benzphetamine—Selegiline—CYP3A4—bone cancer	0.000249	0.0496	CrCbGaD
Benzphetamine—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.000225	0.0387	CbGpPWpGaD
Benzphetamine—Modafinil—CYP3A4—bone cancer	0.000219	0.0437	CrCbGaD
Benzphetamine—Dextropropoxyphene—CYP3A4—bone cancer	0.000217	0.0432	CrCbGaD
Benzphetamine—Fentanyl—CYP3A4—bone cancer	0.000215	0.0428	CrCbGaD
Benzphetamine—Phenytoin—CYP3A4—bone cancer	0.000195	0.0388	CrCbGaD
Benzphetamine—Atomoxetine—CYP3A4—bone cancer	0.000189	0.0376	CrCbGaD
Benzphetamine—Phenoxybenzamine—CYP3A4—bone cancer	0.000182	0.0362	CrCbGaD
Benzphetamine—Trimipramine—CYP3A4—bone cancer	0.000155	0.0309	CrCbGaD
Benzphetamine—Tamoxifen—CYP3A4—bone cancer	0.000148	0.0296	CrCbGaD
Benzphetamine—Methadone—CYP3A4—bone cancer	0.000147	0.0293	CrCbGaD
Benzphetamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000145	0.0249	CbGpPWpGaD
Benzphetamine—Orphenadrine—CYP3A4—bone cancer	0.000144	0.0287	CrCbGaD
Benzphetamine—Promazine—CYP3A4—bone cancer	0.000131	0.0262	CrCbGaD
Benzphetamine—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.00013	0.0222	CbGpPWpGaD
Benzphetamine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000122	0.0209	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.000115	0.0198	CbGpPWpGaD
Benzphetamine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000115	0.0197	CbGpPWpGaD
Benzphetamine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	8.89e-05	0.0152	CbGpPWpGaD
Benzphetamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	8.47e-05	0.0145	CbGpPWpGaD
Benzphetamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	6.59e-05	0.0113	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS1—bone cancer	5.89e-05	0.0101	CbGpPWpGaD
Benzphetamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	5.38e-05	0.00922	CbGpPWpGaD
Benzphetamine—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	5.31e-05	0.0091	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	5.25e-05	0.009	CbGpPWpGaD
Benzphetamine—ADRA2A—Regulation of insulin secretion—GNA11—bone cancer	5.18e-05	0.00888	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.42e-05	0.00758	CbGpPWpGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	4.36e-05	0.00747	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—GRM1—bone cancer	4.26e-05	0.0073	CbGpPWpGaD
Benzphetamine—ADRA2A—Integration of energy metabolism—GNA11—bone cancer	4.07e-05	0.00699	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.81e-05	0.00654	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	3.81e-05	0.00653	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—GRM4—bone cancer	3.8e-05	0.00651	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—RGS1—bone cancer	3.8e-05	0.00651	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—GSTP1—bone cancer	3.78e-05	0.00648	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—TGFBR2—bone cancer	3.78e-05	0.00648	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TGFBR2—bone cancer	3.35e-05	0.00574	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—GSTP1—bone cancer	3.35e-05	0.00574	CbGpPWpGaD
Benzphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	3.29e-05	0.00564	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.97e-05	0.0051	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—BRAF—bone cancer	2.8e-05	0.0048	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—GNA11—bone cancer	2.74e-05	0.0047	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.63e-05	0.00452	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.57e-05	0.0044	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—GRM4—bone cancer	2.48e-05	0.00424	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	2.45e-05	0.00421	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SPARC—bone cancer	2.44e-05	0.00418	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—MDM2—bone cancer	2.35e-05	0.00403	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	2.32e-05	0.00397	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—GRM4—bone cancer	2.3e-05	0.00394	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	2.28e-05	0.00392	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.27e-05	0.0039	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—GNA11—bone cancer	2.23e-05	0.00382	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—BRAF—bone cancer	2.15e-05	0.00368	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—GRM1—bone cancer	2.15e-05	0.00368	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IL3—bone cancer	2.02e-05	0.00347	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—GRM1—bone cancer	1.99e-05	0.00342	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTP1—bone cancer	1.98e-05	0.0034	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	1.95e-05	0.00335	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—MDM2—bone cancer	1.8e-05	0.00308	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—BRAF—bone cancer	1.67e-05	0.00286	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—SMO—bone cancer	1.51e-05	0.00259	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NDUFA12—bone cancer	1.48e-05	0.00254	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—TP53—bone cancer	1.46e-05	0.0025	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—SMO—bone cancer	1.41e-05	0.00241	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—MDM2—bone cancer	1.4e-05	0.0024	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	1.4e-05	0.0024	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	1.4e-05	0.0024	CbGpPWpGaD
Benzphetamine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.39e-05	0.00238	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NDUFA12—bone cancer	1.39e-05	0.00238	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	1.3e-05	0.00223	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	1.3e-05	0.00223	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—BRAF—bone cancer	1.28e-05	0.00219	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—RGS1—bone cancer	1.27e-05	0.00218	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GRM4—bone cancer	1.27e-05	0.00218	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SPARC—bone cancer	1.26e-05	0.00215	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NT5C3A—bone cancer	1.23e-05	0.0021	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	1.21e-05	0.00208	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—RGS1—bone cancer	1.18e-05	0.00202	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GRM4—bone cancer	1.18e-05	0.00202	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NT5C3A—bone cancer	1.15e-05	0.00197	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—GNA11—bone cancer	1.15e-05	0.00197	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	1.13e-05	0.00193	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GRM1—bone cancer	1.1e-05	0.00189	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—MDM2—bone cancer	1.07e-05	0.00184	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IL3—bone cancer	1.04e-05	0.00179	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GRM1—bone cancer	1.02e-05	0.00175	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTP1—bone cancer	9e-06	0.00154	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	8.88e-06	0.00152	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	7.82e-06	0.00134	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—SMO—bone cancer	7.76e-06	0.00133	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RGS1—bone cancer	7.5e-06	0.00129	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GRM4—bone cancer	7.5e-06	0.00129	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	7.26e-06	0.00125	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—SMO—bone cancer	7.21e-06	0.00124	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	7.1e-06	0.00122	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	7.09e-06	0.00121	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.98e-06	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RGS1—bone cancer	6.97e-06	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GRM4—bone cancer	6.97e-06	0.0012	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLAU—bone cancer	6.83e-06	0.00117	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	6.6e-06	0.00113	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	6.58e-06	0.00113	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GRM1—bone cancer	6.51e-06	0.00112	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL3—bone cancer	6.44e-06	0.0011	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NDUFA12—bone cancer	6.31e-06	0.00108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GRM1—bone cancer	6.05e-06	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL3—bone cancer	5.98e-06	0.00103	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ENO2—bone cancer	5.37e-06	0.000921	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NT5C3A—bone cancer	5.23e-06	0.000896	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ENO2—bone cancer	5.04e-06	0.000864	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—DHFR—bone cancer	4.99e-06	0.000855	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—DHFR—bone cancer	4.67e-06	0.000801	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GNA11—bone cancer	4.66e-06	0.000799	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SMO—bone cancer	4.58e-06	0.000786	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GNA11—bone cancer	4.37e-06	0.000749	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SMO—bone cancer	4.26e-06	0.00073	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP3A4—bone cancer	4.22e-06	0.000724	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GNA11—bone cancer	4.19e-06	0.000719	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP3A4—bone cancer	3.96e-06	0.000679	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ATF1—bone cancer	3.9e-06	0.000668	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GNA11—bone cancer	3.9e-06	0.000668	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL3—bone cancer	3.8e-06	0.000652	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ATF1—bone cancer	3.62e-06	0.000621	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTP1—bone cancer	3.61e-06	0.000619	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL3—bone cancer	3.53e-06	0.000606	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTP1—bone cancer	3.39e-06	0.000581	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	3.25e-06	0.000557	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	3.06e-06	0.000524	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	3.02e-06	0.000518	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	2.84e-06	0.000487	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—bone cancer	2.75e-06	0.000471	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ENO2—bone cancer	2.29e-06	0.000393	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KIT—bone cancer	2.22e-06	0.00038	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—DHFR—bone cancer	2.12e-06	0.000364	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BRAF—bone cancer	2.09e-06	0.000358	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KIT—bone cancer	2.06e-06	0.000353	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	2.02e-06	0.000347	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GNA11—bone cancer	1.99e-06	0.00034	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.94e-06	0.000332	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.88e-06	0.000322	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—bone cancer	1.87e-06	0.000321	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—bone cancer	1.75e-06	0.000301	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.75e-06	0.0003	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.62e-06	0.000278	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTP1—bone cancer	1.54e-06	0.000264	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—JUN—bone cancer	1.52e-06	0.00026	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.48e-06	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—JUN—bone cancer	1.41e-06	0.000242	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—bone cancer	1.37e-06	0.000235	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EGFR—bone cancer	1.19e-06	0.000205	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EGFR—bone cancer	1.11e-06	0.00019	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—bone cancer	1e-06	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—bone cancer	9.31e-07	0.00016	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—bone cancer	7.97e-07	0.000137	CbGpPWpGaD
